IRVINE, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) — Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced the conditional acceptance from the U.S. Food and Drug Administration (“FDA”) of the Jeuveau™…Original Article
Evolus Receives Conditional FDA Acceptance of Jeuveau Brand Name
